An opposite scenario was observed in the male PRL+ GBM population, in which the upregulation of PRLR was associated to a significant reduction in the median survival when compared to patients with PRLRLOW GBM, who exhibited a striking 17-mos. This evidence concerns the gene PRLR and glioblastoma.